Verb Tech (NASDAQ:VERB) reported quarterly sales of $2.20 million which missed the analyst consensus estimate of $2.95 million by 25.42 percent. This is a 24.14 percent decrease over sales of $2.90 million the same period last year.
Atea Pharmaceuticals Q3 EPS $(0.10) Beats $(0.44) Estimate
Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.44) by 77.27 percent. This is a 70.59 percent increase over losses of $(0.34) per share
